• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体与皮肤自身免疫性水疱病

Complement and cutaneous autoimmune blistering diseases.

作者信息

Lessey Elizabeth, Li Ning, Diaz Luis, Liu Zhi

机构信息

Department of Dermatology, University of North Carolina, Chapel Hill, NC 27599, USA.

出版信息

Immunol Res. 2008;41(3):223-32. doi: 10.1007/s12026-008-8028-y.

DOI:10.1007/s12026-008-8028-y
PMID:18641925
Abstract

Cutaneous autoimmune blistering diseases are associated with tissue injury and fluid accumulation within the skin. The initial trigger for the organ-specific damage is autoantibodies targeting skin autoantigens, which are involved in cell-cell or cell-matrix adhesion in the skin. Pemphigus autoantibodies bind to desmosomal antigens and cause intraepidermal blisters, while pemphigoid autoantibodies interact with hemidesmosomal or hemidesmosome-associated antigens and lead to dermal-epidermal junction separation. Local complement activation is a common feature for these skin blistering diseases and some complement components are readily detected in the lesional skin and blister fluids. This review summarizes the current knowledge on the role the complement system in skin blister formation. Characterization of the pathogenically relevant complement cascade and relative contribution of different pathways into complement activation provides new insights of disease pathology and may help develop better therapeutic strategies for these potentially fatal cutaneous blistering disorders.

摘要

皮肤自身免疫性水疱病与皮肤组织损伤和液体蓄积有关。器官特异性损伤的初始触发因素是针对皮肤自身抗原的自身抗体,这些自身抗原参与皮肤中的细胞 - 细胞或细胞 - 基质黏附。天疱疮自身抗体与桥粒抗原结合并导致表皮内水疱形成,而类天疱疮自身抗体与半桥粒或半桥粒相关抗原相互作用并导致真皮 - 表皮连接分离。局部补体激活是这些皮肤水疱病的共同特征,并且在皮损皮肤和水疱液中很容易检测到一些补体成分。本综述总结了关于补体系统在皮肤水疱形成中作用的当前知识。对致病相关补体级联的表征以及不同途径对补体激活的相对贡献为疾病病理学提供了新的见解,并可能有助于为这些潜在致命的皮肤水疱病制定更好的治疗策略。

相似文献

1
Complement and cutaneous autoimmune blistering diseases.补体与皮肤自身免疫性水疱病
Immunol Res. 2008;41(3):223-32. doi: 10.1007/s12026-008-8028-y.
2
Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.大疱性类天疱疮和获得性大疱性表皮松解症患者的自身抗体诱导真皮-表皮分离需要粒细胞衍生的弹性蛋白酶和明胶酶B。
J Pathol. 2004 Dec;204(5):519-27. doi: 10.1002/path.1674.
3
Bullous pemphigoid autoantibodies directly induce blister formation without complement activation.大疱性类天疱疮自身抗体可直接诱导水疱形成,而无需补体激活。
J Immunol. 2014 Nov 1;193(9):4415-28. doi: 10.4049/jimmunol.1400095. Epub 2014 Sep 26.
4
Bullous pemphigoid: role of complement and mechanisms for blister formation within the lamina lucida.大疱性类天疱疮:补体的作用和在透明层内水疱形成的机制。
Exp Dermatol. 2013 Jun;22(6):381-5. doi: 10.1111/exd.12146. Epub 2013 May 7.
5
Pathogenesis of epidermolysis bullosa acquisita, an autoimmune subepidermal bullous disease.获得性大疱性表皮松解症的发病机制,一种自身免疫性表皮下水疱病。
J Pathol. 2012 Sep;228(1):1-7. doi: 10.1002/path.4062. Epub 2012 Jul 26.
6
The Autoimmune Skin Disease Bullous Pemphigoid: The Role of Mast Cells in Autoantibody-Induced Tissue Injury.自身免疫性皮肤病大疱性类天疱疮:肥大细胞在自身抗体诱导的组织损伤中的作用。
Front Immunol. 2018 Mar 1;9:407. doi: 10.3389/fimmu.2018.00407. eCollection 2018.
7
Human IgG1 monoclonal antibody against human collagen 17 noncollagenous 16A domain induces blisters via complement activation in experimental bullous pemphigoid model.针对人胶原蛋白 17 非胶原 16A 结构域的人 IgG1 单克隆抗体通过补体激活在实验性大疱性类天疱疮模型中诱导水疱。
J Immunol. 2010 Dec 15;185(12):7746-55. doi: 10.4049/jimmunol.1000667. Epub 2010 Nov 12.
8
IgG4, complement, and the mechanisms of blister formation in pemphigus and bullous pemphigoid.IgG4、补体与天疱疮和大疱性类天疱疮水疱形成的机制。
J Dermatol Sci. 2017 Dec;88(3):265-270. doi: 10.1016/j.jdermsci.2017.07.012. Epub 2017 Jul 18.
9
The desmosome and hemidesmosome in cutaneous autoimmunity.皮肤自身免疫中的桥粒和半桥粒
Clin Exp Immunol. 1997 Jan;107 Suppl 1:9-15.
10
Immunopathology and molecular diagnosis of autoimmune bullous diseases.自身免疫性大疱性疾病的免疫病理学与分子诊断
J Cell Mol Med. 2007 May-Jun;11(3):462-81. doi: 10.1111/j.1582-4934.2007.00033.x.

引用本文的文献

1
Advancements in Bullous Pemphigoid Treatment: A Comprehensive Pipeline Update.大疱性类天疱疮治疗的进展:全面的药物研发管线更新。
Am J Clin Dermatol. 2024 Mar;25(2):195-212. doi: 10.1007/s40257-023-00832-1. Epub 2023 Dec 29.
2
Bullous Pemphygoid and Novel Therapeutic Approaches.大疱性类天疱疮与新型治疗方法
Biomedicines. 2022 Nov 8;10(11):2844. doi: 10.3390/biomedicines10112844.
3
The relevance of complement in pemphigoid diseases: A critical appraisal.补体在天疱疮疾病中的相关性:批判性评价。

本文引用的文献

1
Autoimmunity to type VII collagen: epidermolysis bullosa acquisita.对VII型胶原蛋白的自身免疫:获得性大疱性表皮松解症。
Curr Dir Autoimmun. 2008;10:195-205. doi: 10.1159/000131455.
2
Complement deficiencies and systemic lupus erythematosus.补体缺陷与系统性红斑狼疮
Autoimmunity. 2007 Dec;40(8):560-6. doi: 10.1080/08916930701510673.
3
The role of complement in inflammatory diseases from behind the scenes into the spotlight.补体在炎症性疾病中的作用从幕后走向了聚光灯下。
Front Immunol. 2022 Aug 16;13:973702. doi: 10.3389/fimmu.2022.973702. eCollection 2022.
4
Role of Regulatory Immune Cells and Molecules in Autoimmune Bullous Dermatoses.调节性免疫细胞和分子在自身免疫性大疱性皮肤病中的作用。
Front Immunol. 2019 Aug 2;10:1746. doi: 10.3389/fimmu.2019.01746. eCollection 2019.
5
Decreased expression levels of complement regulator CD55 contribute to the development of bullous pemphigoid.补体调节蛋白CD55表达水平降低促成大疱性类天疱疮的发展。
Oncotarget. 2017 Sep 23;9(85):35517-35527. doi: 10.18632/oncotarget.21216. eCollection 2018 Oct 30.
6
Complement Activation in Inflammatory Skin Diseases.补体激活在炎症性皮肤疾病中的作用。
Front Immunol. 2018 Apr 16;9:639. doi: 10.3389/fimmu.2018.00639. eCollection 2018.
7
Dysregulation of mCD46 and sCD46 contribute to the pathogenesis of bullous pemphigoid.mCD46 和 sCD46 的失调导致大疱性类天疱疮的发病机制。
Sci Rep. 2017 Mar 10;7(1):145. doi: 10.1038/s41598-017-00235-3.
8
Classical complement pathway activation in the nasal tissue of patients with chronic rhinosinusitis.慢性鼻窦炎患者鼻腔组织中的经典补体途径激活
J Allergy Clin Immunol. 2017 Jul;140(1):89-100.e2. doi: 10.1016/j.jaci.2016.11.015. Epub 2016 Dec 12.
9
Complement, a target for therapy in inflammatory and degenerative diseases.补体,炎症和退行性疾病的治疗靶点。
Nat Rev Drug Discov. 2015 Dec;14(12):857-77. doi: 10.1038/nrd4657. Epub 2015 Oct 23.
10
Complement system in dermatological diseases - fire under the skin.皮肤疾病中的补体系统——皮下之火。
Front Med (Lausanne). 2015 Jan 29;2:3. doi: 10.3389/fmed.2015.00003. eCollection 2015.
Am J Pathol. 2007 Sep;171(3):715-27. doi: 10.2353/ajpath.2007.070166. Epub 2007 Jul 19.
4
The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita.补体激活的替代途径对于实验性获得性大疱性表皮松解症中的水疱形成至关重要。
J Immunol. 2007 May 15;178(10):6514-21. doi: 10.4049/jimmunol.178.10.6514.
5
Humanization of autoantigen.自身抗原人源化
Nat Med. 2007 Mar;13(3):378-83. doi: 10.1038/nm1496. Epub 2007 Feb 25.
6
The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases.自身免疫性大疱性皮肤病中自身抗体的IgG亚类与水疱形成的相关性。
Arch Dermatol Res. 2007 Apr;299(1):1-8. doi: 10.1007/s00403-007-0734-0. Epub 2007 Feb 3.
7
Cutaneous lupus erythematosus: understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies.皮肤型红斑狼疮:对疾病临床特征、遗传基础及病理生物学的理解指导治疗策略。
Autoimmunity. 2006 Sep;39(6):433-44. doi: 10.1080/08916930600886851.
8
Role of different pathways of the complement cascade in experimental bullous pemphigoid.补体级联反应不同途径在实验性大疱性类天疱疮中的作用
J Clin Invest. 2006 Nov;116(11):2892-900. doi: 10.1172/JCI17891. Epub 2006 Oct 5.
9
Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice.诱导针对VII型胶原蛋白的补体结合自身抗体会导致小鼠出现表皮下水疱。
J Immunol. 2006 Sep 1;177(5):3461-8. doi: 10.4049/jimmunol.177.5.3461.
10
Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients.通过被动转移患者的自身抗体在小鼠中诱导获得性大疱性表皮松解症。
J Invest Dermatol. 2006 Jun;126(6):1323-30. doi: 10.1038/sj.jid.5700254.